Nociceptor interleukin 10 receptor 1 is critical for muscle analgesia induced by repeated bouts of eccentric exercise in the rat
- PMID: 28628078
- PMCID: PMC5515690
- DOI: 10.1097/j.pain.0000000000000936
Nociceptor interleukin 10 receptor 1 is critical for muscle analgesia induced by repeated bouts of eccentric exercise in the rat
Abstract
Delayed-onset muscle soreness is typically observed after strenuous or unaccustomed eccentric exercise. Soon after recovery, blunted muscle soreness is observed on repeated eccentric exercise, a phenomenon known as repeated bout effect (RBE). Although regular physical activity decreases muscle hyperalgesia, likely because of increased production of the anti-inflammatory cytokine interleukin-10 (IL-10) in the skeletal muscle, whether IL-10 also contributes to the antinociceptive effect of RBE is unknown. Furthermore, whether IL-10 attenuates muscle hyperalgesia by acting on muscle nociceptors remains to be established. Here, we explored the hypothesis that blunted muscle nociception observed in RBE depends on a local effect of IL-10, acting on IL-10 receptor 1 (IL-10R1) expressed by muscle nociceptors. Results show that after a second bout of eccentric exercise, rats exhibited decreased muscle hyperalgesia, indicative of RBE, and increased expression of IL-10 in the exercised gastrocnemius muscle. Although knockdown of IL-10R1 protein in nociceptors innervating the gastrocnemius muscle by intrathecal antisense oligodeoxynucleotide did not change nociceptive threshold in naive rats, it unveiled latent muscle hyperalgesia in rats submitted to eccentric exercise 12 days ago. Furthermore, antisense also prevented the reduction of muscle hyperalgesia observed after a second bout of eccentric exercise. These data indicate that recovery of nociceptive threshold after eccentric exercise and RBE-induced analgesia depend on a local effect of IL-10, acting on its canonical receptor in muscle nociceptors.
Figures




Similar articles
-
Eccentric exercise induces chronic alterations in musculoskeletal nociception in the rat.Eur J Neurosci. 2010 Sep;32(5):819-25. doi: 10.1111/j.1460-9568.2010.07359.x. Epub 2010 Aug 19. Eur J Neurosci. 2010. PMID: 20726881 Free PMC article.
-
IB4(+) nociceptors mediate persistent muscle pain induced by GDNF.J Neurophysiol. 2012 Nov;108(9):2545-53. doi: 10.1152/jn.00576.2012. Epub 2012 Aug 22. J Neurophysiol. 2012. PMID: 22914655 Free PMC article.
-
Serial sarcomerogenesis does not contribute to the initial repeated bout effect in skeletal muscle.J Biomech. 2025 Jun;187:112767. doi: 10.1016/j.jbiomech.2025.112767. Epub 2025 May 17. J Biomech. 2025. PMID: 40403600
-
Recent advances in the understanding of the repeated bout effect: the protective effect against muscle damage from a single bout of eccentric exercise.Scand J Med Sci Sports. 2003 Apr;13(2):88-97. doi: 10.1034/j.1600-0838.2003.02477.x. Scand J Med Sci Sports. 2003. PMID: 12641640 Review.
-
Does exercise increase or decrease pain? Central mechanisms underlying these two phenomena.J Physiol. 2017 Jul 1;595(13):4141-4150. doi: 10.1113/JP273355. Epub 2017 May 26. J Physiol. 2017. PMID: 28369946 Free PMC article. Review.
Cited by
-
Mechanisms Mediating High-Molecular-Weight Hyaluronan-Induced Antihyperalgesia.J Neurosci. 2020 Aug 19;40(34):6477-6488. doi: 10.1523/JNEUROSCI.0166-20.2020. Epub 2020 Jul 14. J Neurosci. 2020. PMID: 32665406 Free PMC article.
-
Effects of spinal non-viral interleukin-10 gene therapy formulated with d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein analysis in pain relevant tissues.Brain Behav Immun. 2018 Mar;69:91-112. doi: 10.1016/j.bbi.2017.11.004. Epub 2017 Nov 4. Brain Behav Immun. 2018. PMID: 29113923 Free PMC article.
-
Immune drivers of pain resolution and protection.Nat Immunol. 2024 Dec;25(12):2200-2208. doi: 10.1038/s41590-024-02002-9. Epub 2024 Nov 11. Nat Immunol. 2024. PMID: 39528810 Review.
-
No immediate change in systemic cytokines following an eccentric muscle training session in people with multiple sclerosis.Ther Adv Neurol Disord. 2024 Jul 31;17:17562864241266113. doi: 10.1177/17562864241266113. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 39091997 Free PMC article.
-
Adenosine A3 agonists reverse neuropathic pain via T cell-mediated production of IL-10.J Clin Invest. 2021 Apr 1;131(7):e139299. doi: 10.1172/JCI139299. J Clin Invest. 2021. PMID: 33621215 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources